Trial Summary
What is the purpose of this trial?
This study involves both the development of a novel learning tool, the Radiation Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this tool as an effective resource to teach treatment plan review and optimization to radiation oncology residents.
Research Team
RJ
Rachel Jimenez, MD
Principal Investigator
Massachusetts General Hospital
Eligibility Criteria
This trial is for radiation oncology resident physicians in their PGY-2, PGY-3, or PGY-4 year. Participants must have finished a breast cancer-specific radiation oncology rotation at least 3 months before joining the study. Special populations are not included.Inclusion Criteria
I am a radiation oncology resident in my 2nd, 3rd, or 4th year.
I completed a breast cancer radiation rotation over 3 months ago.
Exclusion Criteria
The study will not include any special populations.
Treatment Details
Interventions
- Radiation Treatment Plan Evaluation Learning Tool (Behavioral Intervention)
Trial OverviewThe study is testing a new learning module designed to teach treatment plan review and optimization to residents specializing in radiation oncology. It's both about developing this educational tool and checking if it works well as a teaching resource.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Radiation Treatment Plan Evaluation Learning ModuleExperimental Treatment1 Intervention
Radiation oncology resident physicians will complete study procedures as below:
* Initial survey and pre-module examination.
* Learning module.
* Post-module survey and examination.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
Trials
3,066
Recruited
13,430,000+
Dr. William Curry
Massachusetts General Hospital
Chief Medical Officer
MD from Harvard Medical School
Dr. Anne Klibanski
Massachusetts General Hospital
Chief Executive Officer since 2019
MD from Harvard Medical School